Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
A 1 mg dose would be a tiny 0.05 mL (or 5 units), which can be more difficult to measure accurately
Month 9: Interim technical progress briefing (live system demo with annotated slides) to the DARPA PM (in-person or virtual as needed) detailing progress made (include quantitative assessment of capability developed to date), tasks accomplished, major risks/mitigations, planned activities, and technical plan for the remainder of Phase II, the demonstration/verification plan for the end of Phase II, trip summaries, and any potential issues or problem areas that require the attention of the DARPA PM
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
It has a clear and well-understood chemical basis
US$ 23.50
US$ 25.96
US$ 23.35
US$ 24.38
US$ 20.69
US$ 24.92
US$ 20.86
